Relationship between apolipoprotein E, D10S1225 polymorphisms and late-onset Alzheimer's disease

Chinese Medical Journal

Volumn 119, Issue 4, 2006, Pages 294-299

  Zhang, Tai Song ^a   Wang, Hua Qiao ^a   Wang, Wei Yi ^a   He, Yun Shao ^a   Huang, Shao Kuan ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Senile Center   (China)

Author keywords

Alzheimer's disease; Apolipoprotein E; Chromosome 10; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; POLYACRYLAMIDE GEL;

AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 10; CONTROLLED STUDY; DOT HYBRIDIZATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOME SIZE; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RISK FACTOR; SILVER STAINING; STATISTICAL ANALYSIS; ALLELE; FEMALE; GENETICS; MALE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33645280926     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200602020-00005     Document Type: Article

References (15)

1. Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 2000; 290: 2304-2305.
2. Erktekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, et al. Linkage of plasma A-beta-42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000; 290: 2303-2304.
3. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000; 290:2302-2303.
4. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
5. Roses AD. Apolipoprotein E and Alzheimer's. A rapidly expanding field with medical and epidemiological consequences. Ann N Y Acad Sci 1996; 802:50-57.
6. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 2005; 375:1-6.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
8. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387-400.
9. Lung FW, Yen YC, Chou LJ, Hong CJ, Wu CK. The allele interaction between apolipoprotein epsilon2 and epsilon4 in Taiwanese Alzheimer's disease patients. Acta Psychiatr Scand 2005; 111:38-43.
10. Talbot C, Lendon C, Croddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer disease with apoE2. Lancet 1994; 343:1432-1433.
11. Mayeux R, Saunders AM, Shea S, Mina S, Evans D, Roses AD, et al. Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease. N Engl J Med 1998; 338:506-511.
12. Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, et al. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 2004; 63:2332-2340.
13. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, et al. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000;35:1343-1352.
14. Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere ML, Thomas HV, Marshall H, et al. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001; 109:646-652.
15. Boussaha M, Hannequin D, Verpillat P, Brice A, Frebourg T, Campion D. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 2002; 329:121-123.